|
|
||||
|
BIOGRAPHICAL
SKETCH Provide
the following information for the key personnel in the order listed on
Form Page 2. Photocopy this page or follow this format for each person. |
||||
|
|
||||
|
NAME Guido K.W. Frank |
POSITION
TITLE Research Fellow |
|||
|
EDUCATION/TRAINING (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) |
||||
|
INSTITUTION AND LOCATION |
DEGREE (If applicable) |
YEAR(s) |
FIELD OF STUDY |
|
|
Ludwig-Maximilians-Universitaet
Munich, Germany Psychosomatic
Hospital Roseneck, Prien, Germany (Ludwig-Maximilians-University Munich,
Germany) Psychosomatic
Hospital Roseneck, Prien, Germany (Ludwig-Maximilians-University Munich,
Germany) Center
for Overcoming Problem Eating, Western Psychiatric Institute and Clinic,
Pittsburgh, PA Residency Training Program, Western Psychiatric Institute and Clinic, Pittsburgh, PA Residency Training Program, Western Psychiatric Institute and Clinic, Pittsburgh,
PA NIMH Research Fellowship
T32-MH18399, Biological Psychiatry and Neuroscience, combined with
training in Child and Adolescent Psychiatry, Department of Psychiatry,
University of California, San Diego |
M.D. Intern Resident Research Fellow Intern Resident Research Fellow |
1988-1994 1995-1996 1996-1997 1998
to date 2001-2002 2002-2004 2004
to date |
Medicine Medicine Psychiatry Psychiatry Adult
Psychiatry Adult
Psychiatry Research,
Child and Adolescent Psychiatry |
|
PROFESSIONAL EXPERIENCE:
1995-1996 Internship
at the Psychosomatic Hospital Roseneck / Ludwig-Maximilians-University Munich
1996-1997 Psychiatry
Resident at the Psychosomatic Hospital Roseneck / Ludwig-Maximilians-
University Munich
1994-1997 Doctoral
Program (Thesis)
1998 to date
Research Fellow at the Center for Overcoming Problem Eating, Western
Psychiatric
Institute and Clinic, Pittsburgh, PA
2001-2004 Internship
and Adult Psychiatry Residency, Western Psychiatric Institute and Clinic,
Pittsburgh, PA
2004 to date
NIMH Research
Fellowship T32-MH18399, Biological Psychiatry and Neuroscience, Department of
Psychiatry, UCSD, combined with clinical
training in Child and Adolescent Psychiatry, UCSD Child and Adolescent
Psychiatry Training Program, San Diego
HONORS:
1. Christina Barz-Scholarship
Award for the promotion of research in the field of eating disorders, July 1997
2. Pilot / Feasibility Grant Award, Obesity and Nutrition
Research Center, University of Pittsburgh, PA, January 2000
3. NARSAD Young Investigator Award, March 2001
4. Society of Biological Psychiatry Lilly Travel Fellowship
Award, May 2004,
5. Workshop on
Clinical Trials Travel Fellowship, American Society of Clinical
Psychopharmacology (ASCP), May 2004
6. American Academy of
Child and Adolescent Psychiatry, Outstanding Child and Adolescent Psychiatry
Resident Award, September, 2004
7. Fellow in the Group for the Advancement of Psychiatry
(Period 2005-2007), December 2004
8. Forest Laboratories/West Coast College of Biological
Psychiatry Junior Faculty Award, March 2005
PUBLICATIONS:
Articles
1.
Spannagl M, Trauner A, Birg A, Frank G, Hoffmann H, Siebeck M, Lill H.
Sensitive detection of the activation state of blood coagulation in porcine DIC
models by a new fibrin immunoassay. Blood Coag Fibrinol, 1993, Vol. Nr. 4,
103-106.
2.
Spannagl M, Frank G, Goedde M, Hoffmann H. The Xanthine derivatives HWA
138 and A 80 attenuate activation of coagulation in porcine endotoxin shock. In:
Mueller-Berghaus G, Madlener K, Blombeck M, ten Cate JW (eds.): Pathogenesis,
diagnosis and therapy of disseminated intravascular fibrin formation. Amsterdam:
Excerpta Medica International Congress Series Nr. 1044, 1993, pp 239-242.
3.
Hoffmann H, Weis M, Frank G, Birg A, Schoenharting MM, Jochum M.
Amelioration of endotoxin-induced acute lung injury in pigs by HWA 138 and A 80
2715: new analogs of Pentoxifylline. Shock, 1995, Vol. Nr. 4, Nr. 3, pp 166-170.
4.
Cuntz U, Frank G, Fichter MM. Interrelationships between the size of
pancreas and the weight of patients with eating disorders. Int J of Eat Disord
27: 297-303, 2000.
5.
Kaye WH, Frank GK, McConaha C. Altered dopamine activity after recovery
from restricting-type anorexia nervosa. Neuropsychopharmacology (1999), Vol
21:503-506.
6.
Meltzer CC, Cantwell MN, Greer PJ, Ben-Eliezer D, Smith G, Frank G, Kaye
WH, Houck PR, Price JC. Does cerebral blood flow decline in healthy aging? A PET
study with partial-volume correction. J Nucl Med. 2000;41(11):1842-8.
7.
Frank GK, Kaye WH. Sertraline in binge eating/purging type anorexia -
five case reports. Int J Eat Disorders 29(4):495-498, 2001.
8.
Kaye, W.H., Frank, G.K., & Klump, K.L. (2000). Psychophysiology of
obsessional behaviors in anorexia and bulimia nervosa. In L. Bellodi and F.
Brambilla (Eds.), Eating Disorders and Obsessive Compulsive Disorder: An
Etiopathogenetic Link? Turin, Italy: Centro Scientifico Editore.
9.
Frank GK, Kaye WH, Altemus M, Greeno CG. Oxytocin and Vasopressin after
recovery from Bulimia Nervosa and binge-eating/purging type Anorexia Nervosa.
Biol Psychiatry 2000; 48:315-318.
10.
Kaye WH, Frank GK, Meltzer
CC, Price JC, McConaha C, Crossan PJ, Klump KK,
Bernie J. Devlin BJ. Altered medial orbital frontal serotonin receptor
activity after recovery from bulimia nervosa. Am J Psychiatry 158(7):1152-1155,
2001
11.
Frank GK, Kaye WH, Weltzin TE, Perel J, Moss H, McConaha C, Pollice C.
Altered response to m-CPP in anorexia nervosa: support for a persistent
alteration of serotonin activity after short term weight restoration. Int J Eat
Disorders 30(1):57-68, 2001.
12.
Frank GK, Kaye WH, Greer P, Meltzer CC, Price JC. Regional cerebral blood
flow after recovery from bulimia nervosa, and possible relations to state
anxiety and novelty seeking. Psychiatry Research: Neuroimaging 2000.
100(1):31-39.
13.
Frank GK, Kaye WH, Ladenheim EE, McConaha C. Reduced Gastrin Releasing
Peptide in CSF after recovery from Bulimia Nervosa. Appetite 37:871-879, 2001.
14.
Frank GK, Kaye WH, Sahu A, Fernstrom J, McConaha C. Does reduced CSF
Galanin contribute to altered taste related
hedonics in anorexia nervosa? Neuropsychopharmacology
24(6):705-709, 2001
15.
Malina A, Gaskill J, McConaha C, Frank G, LaVia M, Scholar L, Kaye W.
Olanzapine treatment of anorexia nervosa. A retrospective study. Int J
Eat Disord. 2003 Mar;33(2):234-7.
16.
Frank GK, Kaye WH, Meltzer CC, Price JC, Greer P, McConaha C, Skovira K.
Reduced 5-HT2A receptor binding after recovery from anorexia nervosa. Biol
Psychiatry. 2002 Nov 1;52(9):896-906.
17.
Stein
D, Kaye WH, Matsunaga H, Orbach I, Har-Even D, Frank G, McConaha CW, Rao R.
Eating-related concerns, mood, and personality traits in recovered bulimia
nervosa subjects: a replication study. Int J Eat Disord. 2002 Sep;32(2):225-9.
18.
Bailer UF, Frank GK, Henry SE, Price JC, Meltzer CC, Weissfeld L, Mathis
C, Drevets WC, Wagner A, Hoge J, Ziolko SK, McConaha CW, Kaye WH. Increased
Brain Serotonin 5-HT1A Receptor Binding after Recovery from Anorexia
Nervosa Measured by Positron Emission Tomography and [11C]WAY100635.
(Accepted for publication Archives of General Psychiatry).
19.
Barbarich N, McConaha C, Gaskill J, LaVia M. Frank GK, Brooks S, Kaye WH,
Plotnicov K. An open trial of olanzapine in anorexia nervosa. Int J Eat Disord.
2004 Jan;35(1):10-5.
20.
Frank GK, Kaye WH, Carter CS, Brooks S, May C,
Fissel
K, Stenger VA. The evaluation of brain activity in response to taste stimuli-a
pilot study and method for central taste activation as assessed by event-related
fMRI.
J Neurosci Methods. 2003 Dec 30;131(1-2):99-105.
21.
Bailer UF, Price JC, Meltzer CC, Mathis CA, Frank GK, Weissfeld L, et al.
Altered 5-HT2A Receptor Activity after Recovery from Bulimia-type Anorexia
Nervosa: Relationships to Harm Avoidance and Drive for Thinness.
Neuropsychopharmacology. 2004;29(6):1143-55.
Book Chapters and Review Articles
1.
Kaye
WH, Klump K, Frank GK, Strober M. Anorexia and Bulimia
Nervosa. Annu Rev Med 2000. 51:299-313 (Review)
2.
Frank GK. Perspectives for Pharmacological Interventions in Eating Disorders. In:
Handbook of Medical Psychiatry. Gershon S and Soares J (Editors). Marcel Dekker,
New York. 2003. (Book Chapter)
3.
Frank GK,
Bailer UF, Wagner A, Henry S, Kaye WH. Neuroimaging Studies in Eating Disorders.
CNS Spectr. 2004;9(7):539-548 (Review).
